Pangaea Oncology SA
MAD:PANG

Watchlist Manager
Pangaea Oncology SA Logo
Pangaea Oncology SA
MAD:PANG
Watchlist
Price: 1.71 EUR
Market Cap: 58.8m EUR

Wall Street
Price Targets

PANG Price Targets Summary
Pangaea Oncology SA

There are no price targets for PANG.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Pangaea Oncology SA Competitors:
Price Targets
CTKB
Cytek Biosciences Inc
18% Upside
603127
Joinn Laboratories China Co Ltd
27% Downside
PPGN
PolyPeptide Group AG
42% Upside
TXG
10X Genomics Inc
9% Upside
SFZN
Siegfried Holding AG
53% Upside
LAB
Standard BioTools Inc
3% Downside
688315
Novogene Co Ltd
19% Upside
RVTY
Revvity Inc
19% Upside

Revenue
Forecast

Revenue Estimate
Pangaea Oncology SA

For the last 11 years the compound annual growth rate for Pangaea Oncology SA's revenue is 15%. The projected CAGR for the next 3 years is 13%.

15%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-18%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Pangaea Oncology SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Pangaea Oncology SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
86%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PANG's stock price target?
Not Available

PANG doesn't have any price targets made by Wall Street professionals.

What is Pangaea Oncology SA's Revenue forecast?
Projected CAGR
13%

For the last 11 years the compound annual growth rate for Pangaea Oncology SA's revenue is 15%. The projected CAGR for the next 3 years is 13%.

Back to Top